Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Cash & Current Investments (2016 - 2026)

Organogenesis Holdings has reported Cash & Current Investments over the past 11 years, most recently at $96.1 million for Q4 2025.

  • For Q4 2025, Cash & Current Investments fell 29.41% year-over-year to $96.1 million; the TTM value through Dec 2025 reached $96.1 million, down 29.41%, while the annual FY2025 figure was $96.1 million, 29.41% down from the prior year.
  • Cash & Current Investments for Q4 2025 was $96.1 million at Organogenesis Holdings, up from $64.4 million in the prior quarter.
  • Over five years, Cash & Current Investments peaked at $136.2 million in Q4 2024 and troughed at $487000.0 in Q3 2021.
  • A 5-year average of $84.6 million and a median of $95.5 million in 2024 define the central range for Cash & Current Investments.
  • Biggest five-year swings in Cash & Current Investments: skyrocketed 22080.9% in 2022 and later tumbled 32.19% in 2025.
  • Year by year, Cash & Current Investments stood at $114.5 million in 2021, then decreased by 9.81% to $103.3 million in 2022, then increased by 1.01% to $104.3 million in 2023, then soared by 30.49% to $136.2 million in 2024, then dropped by 29.41% to $96.1 million in 2025.
  • Business Quant data shows Cash & Current Investments for ORGO at $96.1 million in Q4 2025, $64.4 million in Q3 2025, and $73.7 million in Q2 2025.